Newsbenzinga
Neurogene Announces Updated Data From Phase 1/2 Clinical Trial Evaluating NGN-401 Gene Therapy For Treatment Of Females With Rett Syndrome
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…